|
PHF14 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.51309999979676E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.70080000000605E-05 |
| Normal-vs-Stage2 |
1.307570E-01 |
| Normal-vs-Stage3 |
1.058650E-01 |
| Normal-vs-Stage4 |
1.111790E-01 |
| Stage1-vs-Stage2 |
8.029200E-01 |
| Stage1-vs-Stage3 |
2.808200E-01 |
| Stage1-vs-Stage4 |
8.109400E-01 |
| Stage2-vs-Stage3 |
6.172800E-01 |
| Stage2-vs-Stage4 |
9.731400E-01 |
| Stage3-vs-Stage4 |
6.229400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.06619999995505E-06 |
| Normal-vs-AfricanAmerican |
7.575000E-04 |
| Normal-vs-Asian |
2.489400E-01 |
| Caucasian-vs-AfricanAmerican |
5.328000E-01 |
| Caucasian-vs-Asian |
8.500600E-01 |
| AfricanAmerican-vs-Asian |
9.947600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.55510999999553E-05 |
| Normal-vs-Female |
2.41690000002404E-06 |
| Male-vs-Female |
2.363800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.400100E-03 |
| Normal-vs-Extreme_Weight |
1.496050E-03 |
| Normal-vs-Obese |
4.21710000000353E-05 |
| Normal-vs-Extreme_Obese |
2.416000E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.757400E-01 |
| Normal_Weight-vs-Obese |
4.932400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.330600E-01 |
| Extreme_Weight-vs-Obese |
5.004600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.377200E-01 |
| Obese-vs-Extreme_Obese |
5.316400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.180700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.92680000025092E-08 |
| Normal-vs-Age(61-80Yrs) |
6.375300E-04 |
| Normal-vs-Age(81-100Yrs) |
2.772400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.861800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.060800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.002400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.798000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.444600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.558200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.90189974880184E-10 |
| Normal-VS-Type2 PRCC |
2.453400E-01 |
| Normal-VS-KIRP CIMP |
5.614000E-01 |
| Normal-VS-Unclassified PRCC |
2.624500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.79300000000748E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.421900E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
8.783600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.078400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.853360E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.194000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.812300E-02 |
| Normal-vs-N1 |
3.932100E-02 |
| Normal-vs-N2 |
4.295400E-01 |
| N0-vs-N1 |
2.446400E-01 |
| N0-vs-N2 |
9.317800E-01 |
| N1-vs-N2 |
5.674200E-01 |
|
|
